Healthcare

Authors retract influential study linking hydroxychloroquine to mortality risk for coronavirus patients

By David Hogberg
Published June 4, 2020 7:45pm ET
Add Washington Examiner on Google
Authors retract influential study linking hydroxychloroquine to mortality risk for coronavirus patients
Three authors have retracted an influential study on the risks of hydroxychloroquine as a treatment for the COVID-19 virus. The article, published in the journal Lancet, had found that hydroxychloroquine, an anti-malaria drug, increased mortality and heart problems in patients suffering from the coronavirus. It had been cited in criticizing President Trump’s promotion of the […]

Three authors have retracted an influential study on the risks of hydroxychloroquine as a treatment for the COVID-19 virus.

The article, published in the journal Lancet, had found that hydroxychloroquine, an anti-malaria drug, increased mortality and heart problems in patients suffering from the coronavirus. It had been cited in criticizing President Trump’s promotion of the drug as a remedy for the disease.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

COVID-19 Hydroxychloroquine